You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

myeloid

Showing 1 - 25 of 5,741
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial (Dasatinib)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 20, 2023

Acute Myeloid Leukemia Trial in Antalya

Recruiting
  • Acute Myeloid Leukemia
    • Antalya, Turkey
      Antalya Training and Research Hospital
    Jul 29, 2023

    Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse Trial in Xuzhou (anti Tim-3/CD123 CAR-T cell therapy)

    Recruiting
    • Acute Myeloid Leukemia Refractory
    • Acute Myeloid Leukemia, in Relapse
    • anti Tim-3/CD123 CAR-T cell therapy
    • Xuzhou, Jiangsu, China
      Kailin Xu
    Nov 4, 2023

    iN the Real Practice

    Not yet recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Vyxeos liposomal
    • Roma, Italy
      Policlinico Tor Vergata
    Nov 16, 2023

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (CB-012)

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • Acute Myeloid Leukemia Refractory
    • (no location specified)
    Nov 9, 2023

    Patients With Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia, Adult
      • Freiburg, CA, Germany
        Medical Center- University of Freiburg
      Aug 4, 2023

      Acute Myeloid Leukemia Refractory Trial in Lyon (NP137, Azacitidine Injection, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia Refractory
      • Lyon, France
        Centre Léon Bérard
      Nov 30, 2023

      Oral Azacitidine Maintenance Therapy in Korean Acute Myeloid

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Oral azacitidine
      • Seoul, Korea, Republic of
        Bristol-Myers Squibb YH
      Oct 3, 2023

      A Study of c-Kit Mutation as MRD in Acute Myeloid Leukemia

      Not yet recruiting
      • C-KIT Mutation
        • (no location specified)
        Nov 2, 2023

        Acute Myeloid Leukemia Trial (ABBV-787)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • (no location specified)
        Sep 29, 2023

        AML, AML With Mutated NPM1, Hematologic Malignancy Trial (Ziftomenib, Fludarabine, Idarubicin)

        Not yet recruiting
        • AML
        • +11 more
        • (no location specified)
        Aug 14, 2023

        Acute Myeloid Leukemia, MDS Trial (idarubicin, Cytarabine)

        Not yet recruiting
        • Acute Myeloid Leukemia
        • Myelodysplastic Syndromes
        • (no location specified)
        Sep 18, 2023

        Myeloid Leukemia, MDS Trial (IFN-?)

        Not yet recruiting
        • Myeloid Leukemia
        • Myelodysplastic Syndromes
        • (no location specified)
        Nov 15, 2023

        Acute Myeloid Leukemia Trial in Taipei

        Enrolling by invitation
        • Acute Myeloid Leukemia
          • Taipei, Taiwan
            National Taiwan University Hospital
          Aug 9, 2023

          Acute Myeloid Leukemia Trial in Beijing (Ven+CAG)

          Recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Peking University People's Hospital
          Jun 23, 2023

          Acute Myeloid Leukemia Trial in Houston (ASTX727, ASTX029-01)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Houston, Texas
            MD Anderson Cancer Center
          Oct 27, 2023

          Acute Myeloid Leukemia Trial in Beijing (N-acetyl-L-cysteine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Beijing, Beijing, China
            Yuan Kong
          Sep 4, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • Tianjin, China
            Institute of Hematology & Blood Diseases Hospital
          Jul 1, 2023

          Frequency and Risk Factors of Acute Myeloid Leukemia

          Not yet recruiting
          • Myeloid Leukemia
          • Bone marrow aspirite for diagnosis
          • (no location specified)
          Mar 15, 2023

          Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Tumor (BPDCN), Relapse Leukemia Trial in Taiyuan (CD123 targeted

          Recruiting
          • Acute Myeloid Leukemia
          • +3 more
          • CD123 targeted CAR-NK cells
          • Taiyuan, Shanxi, China
            Shanxi Bethune Hospital
          Aug 28, 2023

          Acute Myeloid Leukemia Trial in Tianjin (Mitoxantrone HCl liposome injection, Cytarabine, Homoharringtonine)

          Not yet recruiting
          • Acute Myeloid Leukemia
          • Mitoxantrone hydrochloride liposome injection
          • +3 more
          • (no location specified)
          May 29, 2023

          Intensive Conditioning With Thiotepa Combined With Bu/Flu/Ara-C

          Not yet recruiting
          • Acute Myeloid Leukemia
          • +4 more
            • (no location specified)
            Nov 1, 2023

            PET Tracer Based FDG Signal for Predicting Prognosis in Acute

            Enrolling by invitation
            • Acute Myeloid Leukemia
            • No intervention
            • Guangzhou, Guangdong, China
              First Affiliated Hospital of Jinan University
            Jun 22, 2023

            Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)

            Not yet recruiting
            • Chemotherapy-Induced Thrombocytopenia
            • Hetrombopag Olamine
            • (no location specified)
            Jul 5, 2023

            Acute Myeloid Leukemia, High-Risk and Very High-Risk MDS Trial (SGR-2921)

            Not yet recruiting
            • Acute Myeloid Leukemia
            • High-Risk and Very High-Risk Myelodysplastic Syndromes
            • (no location specified)
            Jul 25, 2023